# Botulism Toxin Injection as a Treatment for Arthritis of the Basal Thumb Joint

> **NCT01045694** · PHASE4 · TERMINATED · sponsor: **University of Missouri-Columbia** · enrollment: 8 (actual)

## Conditions studied

- Arthritis Multiple Joint

## Interventions

- **DRUG:** Botulinum Toxin Type A
- **DRUG:** Steroid - Triamcinolone Acetonide
- **DRUG:** Lidocaine

## Key facts

- **NCT ID:** NCT01045694
- **Lead sponsor:** University of Missouri-Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-03
- **Primary completion:** 2012-08
- **Final completion:** 2015-10
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Unable to acquire additional funding needed to continue this study.
- **Last updated:** 2017-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01045694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01045694, "Botulism Toxin Injection as a Treatment for Arthritis of the Basal Thumb Joint". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01045694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*